SHW Q2 Beat Overshadowed by H2 Margin Risks; WAIT Rating Stays

What happened

Sherwin-Williams' Q2 results showed 7.5% sales growth and 9.5% adjusted EPS growth, underscoring share gains in a weak housing market. However, a planned 8% September price increase faces significant timing and competitive hurdles, raising doubts about full realization and H2 margin expansion. The DeepValue master report already flagged tariff-driven raw material inflation and the challenge of achieving low-single-digit net price, leaving FY2026 EPS guidance of $11.50-$11.90 at risk. Until quarterly filings confirm gross margin expansion and stable volumes, the stock's demanding valuation leaves no room for execution missteps. The investment case hinges on the next few quarterly prints proving the margin bridge is intact.

Implication

The Q2 top- and bottom-line beats may tempt investors, but the real test comes in the second half when the September price increase attempts to offset rising raw material costs. With housing demand still soft and mortgage rates not yet unlocking a volume recovery, SHW's ability to pass through pricing will determine if FY2026 EPS guidance can be met. Management's own forecast of low-single-digit net price/mix indicates the 8% list hike will be diluted by competitive discounting, putting consensus estimates in jeopardy. Given the stock's premium multiple, any margin disappointment could lead to sharp downside, as the bear scenario outlined in the master report targets $290. Waiting for Q3 results provides clarity on the pricing realization and gross margin trajectory before committing capital.

Thesis delta

The new article reinforces existing margin concerns without altering the thesis. Q2 strength was encouraging but not enough to resolve the H2 margin uncertainty. The WAIT rating stands, with the bear case gaining slight weight until pricing effectiveness is proven.